These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 6694162)

  • 1. Inhibition of human dihydrofolate reductase by 4,6-diamino-1,2-dihydro-2,2-dimethyl-1-(substituted-phenyl)-s-triazine s. A quantitative structure-activity relationship analysis.
    Hathaway BA; Guo ZR; Hansch C; Delcamp TJ; Susten SS; Freisheim JH
    J Med Chem; 1984 Feb; 27(2):144-9. PubMed ID: 6694162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative structure-activity relationships of the inhibition of Pneumocystis carinii dihydrofolate reductase by 4,6-diamino-1,2-dihydro-2,2-dimethyl-1-(X-phenyl)-s-triazines.
    Marlowe CK; Selassie CD; Santi DV
    J Med Chem; 1995 Mar; 38(6):967-72. PubMed ID: 7699713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of dihydrofolate reductase. 3. 4.6-Diamino-1,2-dihydro-2,2-dimethyl-1-(2-substituted-phenyl)-s-triazine inhibition of bovine liver and mouse tumor enzymes.
    Kim KH; Dietrich SW; Hansch C; Dolnick BJ; Bertino JR
    J Med Chem; 1980 Nov; 23(11):1248-51. PubMed ID: 7452676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of bovine and rat liver dihydrofolate reductase by 4,6-diamino-1,2-dihydro-2,2-dimethyl-1-(4-substituted-phenyl)-s-triazines.
    Hansch C; Dietrich SW; Fukunaga JY
    J Med Chem; 1981 May; 24(5):544-9. PubMed ID: 7241512
    [No Abstract]   [Full Text] [Related]  

  • 5. Quantitative structure-activity relationship of triazine-antifolate inhibition of Leishmania dihydrofolate reductase and cell growth.
    Booth RG; Selassie CD; Hansch C; Santi DV
    J Med Chem; 1987 Jul; 30(7):1218-24. PubMed ID: 3599028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crystallography, quantitative structure-activity relationships, and molecular graphics in a comparative analysis of the inhibition of dihydrofolate reductase from chicken liver and Lactobacillus casei by 4,6-diamino-1,2-dihydro-2,2-dimethyl-1-(substituted-phenyl)-s-triazine s.
    Hansch C; Hathaway BA; Guo ZR; Selassie CD; Dietrich SW; Blaney JM; Langridge R; Volz KW; Kaufman BT
    J Med Chem; 1984 Feb; 27(2):129-43. PubMed ID: 6420569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of the inhibition of bovine and murine leukemia dihydrofolate reductase by 4,6-diamino-1,2-dihydro-2,2-dimethyl-1-(3-X-phenyl)-s-triazines.
    Guo ZR; Dietrich SW; Hansch C; Dolnick BJ; Bertino JR
    Mol Pharmacol; 1981 Nov; 20(3):649-56. PubMed ID: 7329407
    [No Abstract]   [Full Text] [Related]  

  • 8. A molecular shape analysis and quantitative structure-activity relationship investigation of some triazine-antifolate inhibitors of Leishmania dihydrofolate reductase.
    Koehler MG; Rowberg-Schaefer K; Hopfinger AJ
    Arch Biochem Biophys; 1988 Oct; 266(1):152-61. PubMed ID: 3178219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of triazines as inhibitors of L1210 dihydrofolate reductase and of L1210 cells sensitive and resistant to methotrexate.
    Selassie CD; Strong CD; Hansch C; Delcamp TJ; Freisheim JH; Khwaja TA
    Cancer Res; 1986 Feb; 46(2):744-56. PubMed ID: 3940640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ligand binding studies, preliminary structure-activity relationship and detailed mechanistic characterization of 1-phenyl-6,6-dimethyl-1,3,5-triazine-2,4-diamine derivatives as inhibitors of Escherichia coli dihydrofolate reductase.
    Srinivasan B; Tonddast-Navaei S; Skolnick J
    Eur J Med Chem; 2015 Oct; 103():600-14. PubMed ID: 26414808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative structure-activity relationships of antifolate triazines inhibiting murine tumor cells sensitive and resistant to methotrexate.
    Selassie CD; Hansch C; Khwaja TA; Dias CB; Pentecost S
    J Med Chem; 1984 Mar; 27(3):347-57. PubMed ID: 6699880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of the inhibition of growth of methotrexate-resistant and -sensitive leukemia cells in culture by triazines. Evidence for a new mechanism of cell resistance to methotrexate.
    Selassie CD; Guo Z; Hansch C; Khwaja TA; Pentecost S
    J Med Chem; 1982 Feb; 25(2):157-61. PubMed ID: 7057421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Irreversible enzyme inhibitors. 197. Water-soluble reversible inhibitors of dihydrofolate reductase with potent antitumor activity derived from 4, 6-diamino-1,2-dihydro-2,2-dimethyl-1-phenyl-s-triazine.
    Baker BR; Ashton WT
    J Med Chem; 1973 Mar; 16(3):209-14. PubMed ID: 4733101
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of the inhibition of methotrexate-sensitive and -resistant Lactobacillus casei cell cultures with purified Lactobacillus casei dihydrofolate reductase by 4,6-diamino-1,2-dihydro-2,2-dimethyl-1-(3-substituted-phenyl)-s-triazines. Use of quantitative structure-activity relationships in making inferences about the mechanism of resistance and the structure of the enzyme is situ compared with the enzyme in vitro.
    Coats EA; Genther CS; Dietrich SW; Guo ZR; Hansch C
    J Med Chem; 1981 Dec; 24(12):1422-9. PubMed ID: 6796688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dihydrofolate reductase inhibition. A study in the use of X-ray crystallography, molecular graphics, and quantitative structure-activity relations in drug design.
    Hansch C
    Drug Intell Clin Pharm; 1982 May; 16(5):391-6. PubMed ID: 6806055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conformational analysis of lipophilic antifolates: crystal and molecular structures of three s-triazine dihydrofolate reductase inhibitors.
    Cody V; Sutton PA
    Anticancer Drug Des; 1987 Dec; 2(3):253-62. PubMed ID: 3449089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative structure-activity relationship of antifolate inhibition of bacteria cell cultures resistant and sensitive to methotrexate.
    Coats EA; Genther CS; Selassie CD; Strong CD; Hansch C
    J Med Chem; 1985 Dec; 28(12):1910-6. PubMed ID: 3934385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Irreversible enzyme inhibitors. 196. Active-site-directed irreversible inhibitors of dihydrofolate reductase derived from 1-(4-benzyloxy-3-chlorophenyl)-4,6-diamino-1,2-dihydro-2,2-dimethyl-s-triazine and bearing a terminal phenyl sulfonate group.
    Baker BR; Ashton WT
    J Med Chem; 1972 Sep; 15(9):945-7. PubMed ID: 5051014
    [No Abstract]   [Full Text] [Related]  

  • 19. Quantitative structure-activity relationships by neural networks and inductive logic programming. II. The inhibition of dihydrofolate reductase by triazines.
    Hirst JD; King RD; Sternberg MJ
    J Comput Aided Mol Des; 1994 Aug; 8(4):421-32. PubMed ID: 7815093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Irreversible enzyme inhibitors. CLXXVI. Active-site-directed irreversible inhibitors of dihydrofolate reductase derived from 4,6-diamino-1,2-dihydro-2,2-dimethyl-1-phenyl-s-triazine by ether bridging to a terminal sulfonyl fluoride.
    Baker BR; Ashton WT
    J Med Chem; 1970 Nov; 13(6):1149-54. PubMed ID: 5479855
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.